Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R K Pearce

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|September 24, 1999
L-dopa and dyskinesias in normal monkeysR K Pearce
Professional Nurse (London, England)|September 15, 2000
Developing a competency-based nursing programmeR K Pearce, A Trenerry
Neurology|August 1, 1997
Neuronal loss and plasticity in the supraoptic nucleus in Parkinson's diseaseO Ansorge, S E Daniel, R K Pearce
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
The anterior olfactory nucleus in Parkinson's diseaseR K Pearce, C H Hawkes, S E Daniel
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 1998
De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmosetR K Pearce, T Banerji, P Jenner, et al.
European Journal of Pharmacology|February 13, 2001
Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosetsS Costa, M M Iravani, R K Pearce, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 25, 2000
Chronic supranigral infusion of BDNF in normal and MPTP-treated common marmosetsR K Pearce, S Costa, P Jenner, et al.
Psychopharmacology|August 11, 2001
L-dopa induces dyskinesia in normal monkeys: behavioural and pharmacokinetic observationsR K Pearce, M Heikkilä, I B Lindén, et al.
European Neurology|January 1, 1990
Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophreniaR K Pearce, P Seeman, K Jellinger, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 22, 2001
Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic studyB Y Zeng, R K Pearce, G M MacKenzie, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Movement Disorders : Official Journal of the Movement Disorder Society|September 24, 1999
L-dopa and dyskinesias in normal monkeysR K Pearce
Professional Nurse (London, England)|September 15, 2000
Developing a competency-based nursing programmeR K Pearce, A Trenerry
Neurology|August 1, 1997
Neuronal loss and plasticity in the supraoptic nucleus in Parkinson's diseaseO Ansorge, S E Daniel, R K Pearce
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
The anterior olfactory nucleus in Parkinson's diseaseR K Pearce, C H Hawkes, S E Daniel
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 1998
De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmosetR K Pearce, T Banerji, P Jenner, et al.
European Journal of Pharmacology|February 13, 2001
Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosetsS Costa, M M Iravani, R K Pearce, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 25, 2000
Chronic supranigral infusion of BDNF in normal and MPTP-treated common marmosetsR K Pearce, S Costa, P Jenner, et al.
Psychopharmacology|August 11, 2001
L-dopa induces dyskinesia in normal monkeys: behavioural and pharmacokinetic observationsR K Pearce, M Heikkilä, I B Lindén, et al.
European Neurology|January 1, 1990
Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophreniaR K Pearce, P Seeman, K Jellinger, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 22, 2001
Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic studyB Y Zeng, R K Pearce, G M MacKenzie, et al.
Pageof 4